0.000USD0.000Pre-market 07/24, 09:30 (ET)
433.13MMarket Cap
LossP/E TTM
Pacific Biosciences of California Inc
Key Figures
1.360Open
1.430High
6.86MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
2.21%Turnover Ratio
1.380Prev. Close
1.360Low
7.58MTurnover
LossP/E Static
183.06P/B
0.00%Div Yield TTM
-15.65%ROA
2.73052wk High
0.92Volume Ratio
-309.85MNet Profit
310.49MShares
-0.4133EPS TTM
2.36Beta
-273.55%ROE
0.96052wk Low
5.07%Amplitude
32.30%Gross Margin
433.13MMarket Cap
-0.82Reward/Risk
5.08%Risk Rate
Currency: USD Updated: 2026-07-23 Key Insights
Pacific Biosciences of California Inc's fundamentals are relatively weak, and its growth potential is significant.Its valuation is considered fairly valued, ranking 108 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.46.In the medium term, the stock price is expected to trend down.The company has shown weak stock market performance over the past month, in line with its weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Pacific Biosciences of California Inc's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Pacific Biosciences of California Inc Highlights
StrengthsRisks
Pacific Biosciences of California Inc News
More news coming soon, stay tuned...
Indicators
Pacific Biosciences of California Inc Info
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
Ticker SymbolPACB
CompanyPacific Biosciences of California Inc
CEOHenry (Christian O)
Websitehttps://www.pacb.com/
FAQs
What is the current price of Pacific Biosciences of California Inc (PACB)?
The current price of Pacific Biosciences of California Inc (PACB) is 1.40.
What is the symbol of Pacific Biosciences of California Inc?
The ticker symbol of Pacific Biosciences of California Inc is PACB.
What is the 52-week high of Pacific Biosciences of California Inc?
The 52-week high of Pacific Biosciences of California Inc is 2.73.
What is the 52-week low of Pacific Biosciences of California Inc?
The 52-week low of Pacific Biosciences of California Inc is 0.96.
What is the market capitalization of Pacific Biosciences of California Inc?
The market capitalization of Pacific Biosciences of California Inc is 433.13M.
Is Pacific Biosciences of California Inc (PACB) currently rated as Buy, Hold, or Sell?
According to analysts, Pacific Biosciences of California Inc (PACB) has an overall rating of Buy, with a price target of 2.46.
What is the Earnings Per Share (EPS TTM) of Pacific Biosciences of California Inc (PACB)?
The Earnings Per Share (EPS TTM) of Pacific Biosciences of California Inc (PACB) is -1.82.